These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
312 related articles for article (PubMed ID: 21696190)
1. Characterization of CD44-mediated cancer cell uptake and intracellular distribution of hyaluronan-grafted liposomes. Qhattal HS; Liu X Mol Pharm; 2011 Aug; 8(4):1233-46. PubMed ID: 21696190 [TBL] [Abstract][Full Text] [Related]
2. Hyaluronan polymer length, grafting density, and surface poly(ethylene glycol) coating influence in vivo circulation and tumor targeting of hyaluronan-grafted liposomes. Qhattal HS; Hye T; Alali A; Liu X ACS Nano; 2014 Jun; 8(6):5423-40. PubMed ID: 24806526 [TBL] [Abstract][Full Text] [Related]
3. Targeting gemcitabine containing liposomes to CD44 expressing pancreatic adenocarcinoma cells causes an increase in the antitumoral activity. Dalla Pozza E; Lerda C; Costanzo C; Donadelli M; Dando I; Zoratti E; Scupoli MT; Beghelli S; Scarpa A; Fattal E; Arpicco S; Palmieri M Biochim Biophys Acta; 2013 May; 1828(5):1396-404. PubMed ID: 23384419 [TBL] [Abstract][Full Text] [Related]
4. Synthesis of defined oligohyaluronates-decorated liposomes and interaction with lung cancer cells. Cano ME; Lesur D; Bincoletto V; Gazzano E; Stella B; Riganti C; Arpicco S; Kovensky J Carbohydr Polym; 2020 Nov; 248():116798. PubMed ID: 32919536 [TBL] [Abstract][Full Text] [Related]
5. Cellular uptake and internalization of hyaluronan-based doxorubicin and cisplatin conjugates. Cai S; Alhowyan AA; Yang Q; Forrest WC; Shnayder Y; Forrest ML J Drug Target; 2014 Aug; 22(7):648-57. PubMed ID: 24892741 [TBL] [Abstract][Full Text] [Related]
6. Redox-sensitive and hyaluronic acid functionalized liposomes for cytoplasmic drug delivery to osteosarcoma in animal models. Chi Y; Yin X; Sun K; Feng S; Liu J; Chen D; Guo C; Wu Z J Control Release; 2017 Sep; 261():113-125. PubMed ID: 28666726 [TBL] [Abstract][Full Text] [Related]
7. Hyaluronic Acid-Based pH-Sensitive Polymer-Modified Liposomes for Cell-Specific Intracellular Drug Delivery Systems. Miyazaki M; Yuba E; Hayashi H; Harada A; Kono K Bioconjug Chem; 2018 Jan; 29(1):44-55. PubMed ID: 29183110 [TBL] [Abstract][Full Text] [Related]
8. Hyaluronic acid-coated liposomes for active targeting of gemcitabine. Arpicco S; Lerda C; Dalla Pozza E; Costanzo C; Tsapis N; Stella B; Donadelli M; Dando I; Fattal E; Cattel L; Palmieri M Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):373-80. PubMed ID: 23791684 [TBL] [Abstract][Full Text] [Related]
9. Hyaluronan size alters chondrogenesis of adipose-derived stem cells via the CD44/ERK/SOX-9 pathway. Wu SC; Chen CH; Wang JY; Lin YS; Chang JK; Ho ML Acta Biomater; 2018 Jan; 66():224-237. PubMed ID: 29128538 [TBL] [Abstract][Full Text] [Related]
10. Lipid-based nanosystems for CD44 targeting in cancer treatment: recent significant advances, ongoing challenges and unmet needs. Nascimento TL; Hillaireau H; Vergnaud J; Fattal E Nanomedicine (Lond); 2016 Jul; 11(14):1865-87. PubMed ID: 27389568 [TBL] [Abstract][Full Text] [Related]
11. Evaluating the Efficiency of Hyaluronic Acid for Tumor Targeting via CD44. Spadea A; Rios de la Rosa JM; Tirella A; Ashford MB; Williams KJ; Stratford IJ; Tirelli N; Mehibel M Mol Pharm; 2019 Jun; 16(6):2481-2493. PubMed ID: 31013093 [TBL] [Abstract][Full Text] [Related]
12. Hyaluronic acid-conjugated lipoplexes for targeted delivery of siRNA in a murine metastatic lung cancer model. Leite Nascimento T; Hillaireau H; Vergnaud J; Rivano M; Deloménie C; Courilleau D; Arpicco S; Suk JS; Hanes J; Fattal E Int J Pharm; 2016 Nov; 514(1):103-111. PubMed ID: 27863652 [TBL] [Abstract][Full Text] [Related]
13. Can intracellular drug delivery using hyaluronic acid functionalised pH-sensitive liposomes overcome gemcitabine resistance in pancreatic cancer? Tang M; Svirskis D; Leung E; Kanamala M; Wang H; Wu Z J Control Release; 2019 Jul; 305():89-100. PubMed ID: 31096017 [TBL] [Abstract][Full Text] [Related]
14. Hyaluronan uptake by adult human skin fibroblasts in vitro. Croce MA; Boraldi F; Quaglino D; Tiozzo R; Pasquali-Ronchetti I Eur J Histochem; 2003; 47(1):63-73. PubMed ID: 12685559 [TBL] [Abstract][Full Text] [Related]
15. Molecular weight specific impact of soluble and immobilized hyaluronan on CD44 expressing melanoma cells in 3D collagen matrices. Sapudom J; Ullm F; Martin S; Kalbitzer L; Naab J; Möller S; Schnabelrauch M; Anderegg U; Schmidt S; Pompe T Acta Biomater; 2017 Mar; 50():259-270. PubMed ID: 27965172 [TBL] [Abstract][Full Text] [Related]
17. Hyaluronic acid-nimesulide conjugates as anticancer drugs against CD44-overexpressing HT-29 colorectal cancer in vitro and in vivo. Jian YS; Chen CW; Lin CA; Yu HP; Lin HY; Liao MY; Wu SH; Lin YF; Lai PS Int J Nanomedicine; 2017; 12():2315-2333. PubMed ID: 28392690 [TBL] [Abstract][Full Text] [Related]
18. Hyaluronic acid-bearing lipoplexes: physico-chemical characterization and in vitro targeting of the CD44 receptor. Dufaÿ Wojcicki A; Hillaireau H; Nascimento TL; Arpicco S; Taverna M; Ribes S; Bourge M; Nicolas V; Bochot A; Vauthier C; Tsapis N; Fattal E J Control Release; 2012 Sep; 162(3):545-52. PubMed ID: 22820451 [TBL] [Abstract][Full Text] [Related]
19. Differential involvement of the hyaluronan (HA) receptors CD44 and receptor for HA-mediated motility in endothelial cell function and angiogenesis. Savani RC; Cao G; Pooler PM; Zaman A; Zhou Z; DeLisser HM J Biol Chem; 2001 Sep; 276(39):36770-8. PubMed ID: 11448954 [TBL] [Abstract][Full Text] [Related]
20. Analysis of CD44-hyaluronan interactions in an artificial membrane system: insights into the distinct binding properties of high and low molecular weight hyaluronan. Wolny PM; Banerji S; Gounou C; Brisson AR; Day AJ; Jackson DG; Richter RP J Biol Chem; 2010 Sep; 285(39):30170-80. PubMed ID: 20663884 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]